AR125993A1 - Proceso para la preparacion de compuestos de benzoxazepin oxazolidinona - Google Patents

Proceso para la preparacion de compuestos de benzoxazepin oxazolidinona

Info

Publication number
AR125993A1
AR125993A1 ARP220101413A ARP220101413A AR125993A1 AR 125993 A1 AR125993 A1 AR 125993A1 AR P220101413 A ARP220101413 A AR P220101413A AR P220101413 A ARP220101413 A AR P220101413A AR 125993 A1 AR125993 A1 AR 125993A1
Authority
AR
Argentina
Prior art keywords
optionally substituted
formula
compound
group
salt
Prior art date
Application number
ARP220101413A
Other languages
English (en)
Spanish (es)
Inventor
Remy Bruetsch Tobias Gosselin Francis Han Chong Stutz Alfred Angelaud
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of AR125993A1 publication Critical patent/AR125993A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/02—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof
    • C07C303/04—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups
    • C07C303/06—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of sulfonic acids or halides thereof by substitution of hydrogen atoms by sulfo or halosulfonyl groups by reaction with sulfuric acid or sulfur trioxide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/70—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of the iron group metals or copper
    • B01J23/72—Copper
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C313/00—Sulfinic acids; Sulfenic acids; Halides, esters or anhydrides thereof; Amides of sulfinic or sulfenic acids, i.e. compounds having singly-bound oxygen atoms of sulfinic or sulfenic groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C313/02—Sulfinic acids; Derivatives thereof
    • C07C313/06—Sulfinamides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C07F7/1872—Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892—Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP220101413A 2021-05-28 2022-05-27 Proceso para la preparacion de compuestos de benzoxazepin oxazolidinona AR125993A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202163194382P 2021-05-28 2021-05-28

Publications (1)

Publication Number Publication Date
AR125993A1 true AR125993A1 (es) 2023-08-30

Family

ID=82156627

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP220101413A AR125993A1 (es) 2021-05-28 2022-05-27 Proceso para la preparacion de compuestos de benzoxazepin oxazolidinona

Country Status (13)

Country Link
US (1) US20240166595A1 (cg-RX-API-DMAC10.html)
EP (1) EP4347574A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024520479A (cg-RX-API-DMAC10.html)
KR (1) KR20240013791A (cg-RX-API-DMAC10.html)
CN (1) CN117377660A (cg-RX-API-DMAC10.html)
AR (1) AR125993A1 (cg-RX-API-DMAC10.html)
AU (1) AU2022282440A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023024764A2 (cg-RX-API-DMAC10.html)
CA (1) CA3220273A1 (cg-RX-API-DMAC10.html)
IL (1) IL308457A (cg-RX-API-DMAC10.html)
MX (1) MX2023013919A (cg-RX-API-DMAC10.html)
TW (1) TW202313563A (cg-RX-API-DMAC10.html)
WO (1) WO2022251567A1 (cg-RX-API-DMAC10.html)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI423980B (zh) 2009-09-28 2014-01-21 Hoffmann La Roche 苯并氧氮呯pi3k抑制劑化合物及使用方法
CN111909173B (zh) 2015-07-02 2025-03-04 豪夫迈·罗氏有限公司 苯并氧氮杂䓬噁唑烷酮化合物及其使用方法
PL3851441T3 (pl) * 2016-12-15 2023-11-06 F. Hoffmann-La Roche Ag Proces otrzymywania (S)-2-((2-((S)-4-(difluorometylo)-2-oksooksazolidyn-3-ylo)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oksazepin-9-ylo)amino)propanamidu
AU2019276514B2 (en) * 2018-05-30 2023-12-14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Inhibitor containing tricyclic derivative, preparation method therefor, and application thereof
CN109265408B (zh) * 2018-12-11 2020-09-01 上海皓元生物医药科技有限公司 二氟甲基取代噁烷-2-酮的合成方法

Also Published As

Publication number Publication date
TW202313563A (zh) 2023-04-01
EP4347574A1 (en) 2024-04-10
MX2023013919A (es) 2023-12-08
CA3220273A1 (en) 2022-12-01
KR20240013791A (ko) 2024-01-30
JP2024520479A (ja) 2024-05-24
WO2022251567A1 (en) 2022-12-01
CN117377660A (zh) 2024-01-09
AU2022282440A1 (en) 2023-11-16
BR112023024764A2 (pt) 2024-02-15
IL308457A (en) 2024-01-01
US20240166595A1 (en) 2024-05-23

Similar Documents

Publication Publication Date Title
BR112012018408A2 (pt) composição do combustível diesel, pacote do aditivo, uso de um aditivo e uso de uma composição do combustível diesel.
AR117963A2 (es) Procesos para la preparación de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
BR112012028637A2 (pt) composição de gasolina, pacote de aditivo, uso de aditivo e método
BR112014014148A2 (pt) misturas de ácidos difosfínicos e dialquilfosfínicos, processo para produção das mesmas e uso das mesmas
BR112014013458A2 (pt) microcápsulas, processo de produção de tais microcápsulas e composições utilizando tais microcápsulas
BRPI0708685B8 (pt) composto de 4-oxoquinolina, seu uso e método para produção dos mesmos
JP2010530373A5 (cg-RX-API-DMAC10.html)
CO6470789A2 (es) N-[2´r)-2´-desoxi-2´fluoro-2´-metil-p-fenil-5´uridilil]-l-alanina 1 metiletil éster y proceso para su producción
AR049446A1 (es) Preparacion de pregabalina ((s)-(+)-aminometil-5-metilhexanoico) y compuestos relacionados
AR029658A1 (es) Metodo para la preparacion de citalopram, una composicion farmaceutica antidepresiva, e intermediarios
PE20090758A1 (es) Un proceso para la preparacion de compuestos de aminodiol protegidos con oxazolina, utiles como intermediarios para florfenicol
AR055779A1 (es) Proceso de preparacion de azoxistrobina y composicion que contiene al compuesto
BRPI0814980A8 (pt) Processo para produzir um composto, e, composto.
BR112012024403A2 (pt) processo de preparo de derivados de amino-benzofurano
EA201001110A1 (ru) Непрерывный способ получения амидов алифатических гидроксикарбоновых кислот
EA201600241A1 (ru) Замещенные (2r,3r,5r)-3-гидрокси-(5-пиримидин-1-ил)тетрагидрофуран-2-илметил арил фосфорамидаты
AR049401A1 (es) Aza-biciclononanos
BR112014014347A2 (pt) misturas de ácidos difosfínicos e ácidos alquilfosfônicos, processo para produção das mesmas e uso das mesmas
MX2016005829A (es) Procedimiento para la preparacion de iopamidol.
BR112013030973A2 (pt) processo para a preparação de amidas de prostaglandina
AR087470A1 (es) Derivados imidazolicos bifenilenicos y composiciones farmaceuticas que los contienen
BR112018069712A2 (pt) composto ou um sal farmacologicamente aceitável do mesmo, composição farmacêutica, método para administração de uma quantidade eficaz de uma composição farmacêutica, e, inibidor de tnf-a.
AR069319A1 (es) Metodo para preparar capecitabina y compuesto intermediario de trialquil carbonato.
BR112021024039A2 (pt) Sínteses de furanos substituídos